Literature DB >> 21246216

Long-term outcomes of pneumococcal meningitis in childhood and adolescence.

Deborah Christie1, Russell M Viner, Kyle Knox, Pietro G Coen, Han Wang, Haitham El Bashir, Rosa Legood, Bharat C Patel, Robert Booy.   

Abstract

A vaccine to prevent pneumococcal meningitis (PM) has recently been introduced. However, contemporary data to inform cost-effectiveness analysis and justify its routine use are sparse. We examined the cognitive, educational, psychological and social outcomes of PM in childhood. We completed a population-based case-control study in two regions of the UK. Children and young people currently between 3 and 20 years of age that had been diagnosed with PM ≤14 years of age were identified from active regional surveillance. Controls were siblings or neighbours of similar age. Standardised questionnaires and neuropsychological testing was administered to assess IQ, educational attainments, memory, psychological distress, quality of life and hearing impairment. Data were available on 97 patients and 93 controls. Eighty-four patients had a sibling/neighbour-matched control. Both matched and unmatched analyses were completed, and results of the 84 matched comparisons were highly similar to the unmatched. For the total sample, controls were similar in age, ethnicity and socioeconomic status. Median age at meningitis was 11 months. Median time between meningitis and assessment was 6.0 years. In the matched analysis, partial or profound hearing impairment was reported in 14% of patients and 1% of controls. Patients had significantly lower mean full-scale IQ (p = 0.05), verbal IQ (p = 0.0008), numeracy (p = 0.02), total quality of life (p = 0.04), school functioning (p = 0.005), psychosocial functioning (p = 0.001) and psychological difficulties (p = 0.01). Parents of patients reported greater functional disability (p = 0.008), impairment in all aspects of quality of life (p = 0.001) and psychological difficulties (p < 0.0006). Findings for IQ were not materially different when analyses were repeated only in those without hearing impairment. In multivariate regression analysis that included both case-control status and hearing status, both being a patient (p = 0.001) and having profound hearing impairment (p = 0.001) were independently associated with lower full-scale IQ. Conclusions Pneumococcal meningitis is associated with major sequelae. Our findings strongly support the introduction of pneumococcal conjugate vaccine as part of routine childhood vaccination programmes internationally.

Entities:  

Mesh:

Year:  2011        PMID: 21246216     DOI: 10.1007/s00431-010-1390-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  28 in total

1.  Rising IQ scores in British children: recent evidence.

Authors:  P W Fuggle; S Tokar; D B Grant; I Smith
Journal:  J Child Psychol Psychiatry       Date:  1992-10       Impact factor: 8.982

2.  Health related quality of life in survivors of pneumococcal meningitis.

Authors:  Rosa Legood; Pietro G Coen; Kyle Knox; Russell M Viner; Haitham El Bashir; Deborah Christie; Bharat C Patel; Robert Booy
Journal:  Acta Paediatr       Date:  2008-11-30       Impact factor: 2.299

3.  Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.

Authors:  S B Black; H R Shinefield; J Hansen; L Elvin; D Laufer; F Malinoski
Journal:  Pediatr Infect Dis J       Date:  2001-12       Impact factor: 2.129

4.  Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolates.

Authors:  G Urwin; M F Yuan; L M Hall; K Brown; A Efstratiou; R A Feldman
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

5.  Long-term beneficial effects of dexamethasone on intellectual and neuropsychological outcome of children with pneumococcal meningitis.

Authors:  M Ozen; G Kanra; A Kara; E E Bakar; M Ceyhan; G Secmeer; A B Cengiz
Journal:  Scand J Infect Dis       Date:  2006

6.  Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV).

Authors:  E D G McIntosh; P Conway; J Willingham; R Hollingsworth; A Lloyd
Journal:  Vaccine       Date:  2005-02-25       Impact factor: 3.641

7.  Show me the child at seven II: Childhood intelligence and later outcomes in adolescence and young adulthood.

Authors:  David M Fergusson; L John Horwood; Elizabeth M Ridder
Journal:  J Child Psychol Psychiatry       Date:  2005-08       Impact factor: 8.982

8.  Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands.

Authors:  Jasper M Bos; Hans Rümke; R Welte; M J Postma
Journal:  Clin Ther       Date:  2003-10       Impact factor: 3.393

9.  A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain.

Authors:  Francisco Asensi; Maribel De Jose; Manuel Lorente; Fernando Moraga; Vincent Ciuryla; Steve Arikian; Roman Casciano; Maximo Vento
Journal:  Value Health       Date:  2004 Jan-Feb       Impact factor: 5.725

10.  Adverse outcomes of bacterial meningitis in school-age survivors.

Authors:  K Grimwood; V A Anderson; L Bond; C Catroppa; R L Hore; E H Keir; T Nolan; D M Roberton
Journal:  Pediatrics       Date:  1995-05       Impact factor: 7.124

View more
  13 in total

1.  The burden of pneumococcal meningitis in Austrian children between 2001 and 2008.

Authors:  D S Klobassa; B Zoehrer; M Paulke-Korinek; U Gruber-Sedlmayr; K Pfurtscheller; V Strenger; A Sonnleitner; R Kerbl; B Ausserer; W Arocker; W Kaulfersch; B Hausberger; B Covi; F Eitelberger; A Vécsei; B Simma; R Birnbacher; H Kurz; K Zwiauer; D Weghuber; S Heuberger; F Quehenberger; H Kollaritsch; W Zenz
Journal:  Eur J Pediatr       Date:  2014-01-14       Impact factor: 3.183

2.  Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence.

Authors:  Koen B Pouwels; Eelko Hak; Arie van der Ende; Hannah Christensen; Germie P J M van den Dobbelsteen; Maarten J Postma
Journal:  Hum Vaccin Immunother       Date:  2013-02-13       Impact factor: 3.452

3.  A population-based prospective birth cohort study of childhood neurocognitive and psychological functioning in healthy survivors of early life meningitis.

Authors:  Golam M Khandaker; Jan Stochl; Stanley Zammit; Glyn Lewis; Peter B Jones
Journal:  Ann Epidemiol       Date:  2014-11-20       Impact factor: 3.797

Review 4.  Monetary Valuation of Children's Cognitive Outcomes in Economic Evaluations from a Societal Perspective: A Review.

Authors:  Scott D Grosse; Ying Zhou
Journal:  Children (Basel)       Date:  2021-04-29

5.  Childhood infection and adult schizophrenia: a meta-analysis of population-based studies.

Authors:  Golam M Khandaker; Jorge Zimbron; Christina Dalman; Glyn Lewis; Peter B Jones
Journal:  Schizophr Res       Date:  2012-06-15       Impact factor: 4.939

6.  Cognitive deficits following exposure to pneumococcal meningitis: an event-related potential study.

Authors:  Michael Kihara; Michelle de Haan; Eugene O Were; Harrun H Garrashi; Brian G R Neville; Charles R J C Newton
Journal:  BMC Infect Dis       Date:  2012-03-31       Impact factor: 3.090

7.  The health, social and educational needs of children who have survived meningitis and septicaemia: the parents' perspective.

Authors:  Laura J Clark; Linda Glennie; Suzanne Audrey; Matthew Hickman; Caroline L Trotter
Journal:  BMC Public Health       Date:  2013-10-10       Impact factor: 3.295

Review 8.  Blood‒Brain Barrier Pathology and CNS Outcomes in Streptococcus pneumoniae Meningitis.

Authors:  Belinda Yau; Nicholas H Hunt; Andrew J Mitchell; Lay Khoon Too
Journal:  Int J Mol Sci       Date:  2018-11-11       Impact factor: 5.923

9.  Double deficiency of toll-like receptors 2 and 4 alters long-term neurological sequelae in mice cured of pneumococcal meningitis.

Authors:  Lay Khoon Too; Belinda Yau; Alan G Baxter; Iain S McGregor; Nicholas H Hunt
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

10.  Neuronal Damage and Neuroinflammation, a Bridge Between Bacterial Meningitis and Neurodegenerative Diseases.

Authors:  Kristine Farmen; Miguel Tofiño-Vian; Federico Iovino
Journal:  Front Cell Neurosci       Date:  2021-06-03       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.